136 related articles for article (PubMed ID: 20206477)
1. Macrolide-resistant Streptococcus pyogenes in Central Greece: prevalence; mechanism and molecular identification.
Malli E; Tatsidou E; Damani A; Pantelidi K; Petinaki E; Skoulakis C; Drougka E; Spiliopoulou I
Int J Antimicrob Agents; 2010 Jun; 35(6):614-5. PubMed ID: 20206477
[No Abstract] [Full Text] [Related]
2. Rapid decrease in the prevalence of macrolide-resistant group A streptococci due to the appearance of two epidemic clones in Cantabria (Spain).
Oliver MA; García-Delafuente C; Cano ME; Pérez-Hernández F; Martínez-Martínez L; Albertí S
J Antimicrob Chemother; 2007 Aug; 60(2):450-2. PubMed ID: 17540676
[No Abstract] [Full Text] [Related]
3. Multicentre surveillance of the prevalence and molecular epidemiology of macrolide resistance among pharyngeal isolates of group A streptococci in the USA.
Green MD; Beall B; Marcon MJ; Allen CH; Bradley JS; Dashefsky B; Gilsdorf JR; Schutze GE; Smith C; Walter EB; Martin JM; Edwards KM; Barbadora KA; Wald ER
J Antimicrob Chemother; 2006 Jun; 57(6):1240-3. PubMed ID: 16556634
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of macrolide resistance in Streptococcus pyogenes collected in Serbia.
Pavlovic L; Grego E; Sipetic-Grujicic S
Jpn J Infect Dis; 2010 Jul; 63(4):275-6. PubMed ID: 20657068
[TBL] [Abstract][Full Text] [Related]
5. Plasmid-Borne erm(T) from invasive, macrolide-resistant Streptococcus pyogenes strains.
Woodbury RL; Klammer KA; Xiong Y; Bailiff T; Glennen A; Bartkus JM; Lynfield R; Van Beneden C; Beall BW;
Antimicrob Agents Chemother; 2008 Mar; 52(3):1140-3. PubMed ID: 18180360
[TBL] [Abstract][Full Text] [Related]
6. Decline in macrolide-resistant Streptococcus pyogenes isolates from French children.
d'Humières C; Cohen R; Levy C; Bidet P; Thollot F; Wollner A; Bingen E
Int J Med Microbiol; 2012 Dec; 302(7-8):300-3. PubMed ID: 23103047
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of Streptococcus pyogenes macrolide resistance of paediatric isolates during a 7 year period (2007-13).
Michos A; Koutouzi FI; Tsakris A; Chatzichristou P; Koutouzis EI; Daikos GL; Stathi A; Syriopoulou VP
J Antimicrob Chemother; 2016 Aug; 71(8):2113-7. PubMed ID: 27118782
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic streptococci in Korea.
Uh Y; Jang IH; Hwang GY; Lee MK; Yoon KJ; Kim HY
Antimicrob Agents Chemother; 2004 Jul; 48(7):2716-8. PubMed ID: 15215133
[TBL] [Abstract][Full Text] [Related]
9. Emergence of macrolide-resistant Streptococcus pyogenes strains in French children.
Bingen E; Bidet P; Mihaila-Amrouche L; Doit C; Forcet S; Brahimi N; Bouvet A; Cohen R
Antimicrob Agents Chemother; 2004 Sep; 48(9):3559-62. PubMed ID: 15328126
[TBL] [Abstract][Full Text] [Related]
10. Resistance to bacitracin in Streptococcus pyogenes from oropharyngeal colonization and noninvasive infections in Portugal was caused by two clones of distinct virulence genotypes.
Pires R; Rolo D; Mato R; Feio de Almeida J; Johansson C; Henriques-Normark B; Morais A; Brito-Avô A; Gonçalo-Marques J; Santos-Sanches I
FEMS Microbiol Lett; 2009 Jun; 296(2):235-40. PubMed ID: 19486163
[TBL] [Abstract][Full Text] [Related]
11. Distribution of subclasses mefA and mefE of the mefA gene among clinical isolates of macrolide-resistant (M-phenotype) Streptococcus pneumoniae, viridans group streptococci, and Streptococcus pyogenes.
Ardanuy C; Tubau F; Liñares J; Domínguez MA; Pallarés R; Martín R;
Antimicrob Agents Chemother; 2005 Feb; 49(2):827-9. PubMed ID: 15673780
[TBL] [Abstract][Full Text] [Related]
12. A rapid increase in macrolide resistance in Streptococcus pyogenes isolated in Poland during 1996-2002.
Szczypa K; Sadowy E; Izdebski R; Hryniewicz W
J Antimicrob Chemother; 2004 Oct; 54(4):828-31. PubMed ID: 15329367
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary.
Gattringer R; Sauermann R; Lagler H; Stich K; Buxbaum A; Graninger W; Georgopoulos A
Int J Antimicrob Agents; 2004 Sep; 24(3):290-3. PubMed ID: 15325435
[TBL] [Abstract][Full Text] [Related]
14. Low macrolide resistance in Streptococcus pyogenes in Southern Argentina.
Rubinstein G; Amoroso AM; Bavdaz B; De Bunder S; Blazquez N; Gutkind GO
Int J Antimicrob Agents; 2005 May; 25(5):450-2. PubMed ID: 15848305
[No Abstract] [Full Text] [Related]
15. Erythromycin-resistant group A streptococci.
Shulman ST; Tanz R; Kabat W
N Engl J Med; 2002 Aug; 347(8):614-5; author reply 614-5. PubMed ID: 12195586
[No Abstract] [Full Text] [Related]
16. Rapid inversion of the prevalences of macrolide resistance phenotypes paralleled by a diversification of T and emm types among Streptococcus pyogenes in Portugal.
Silva-Costa C; Ramirez M; Melo-Cristino J;
Antimicrob Agents Chemother; 2005 May; 49(5):2109-11. PubMed ID: 15855540
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Streptococcus invasive locus (sil) and its relationship with macrolide resistance among group A Streptococcus strains.
Billal DS; Hotomi M; Shimada J; Fujihara K; Ubukata K; Sugita R; Yamanaka N
J Clin Microbiol; 2008 Apr; 46(4):1563-4. PubMed ID: 18287313
[No Abstract] [Full Text] [Related]
18. mef(A), mef(E) and a new mef allele in macrolide-resistant Streptococcus spp. isolates from Norway.
Sangvik M; Littauer P; Simonsen GS; Sundsfjord A; Dahl KH
J Antimicrob Chemother; 2005 Nov; 56(5):841-6. PubMed ID: 16172106
[TBL] [Abstract][Full Text] [Related]
19. High macrolide resistance in Streptococcus pyogenes strains isolated from children with pharyngitis in China.
Liu X; Shen X; Chang H; Huang G; Fu Z; Zheng Y; Wang L; Li C; Liu L; Shen Y; Yang Y
Pediatr Pulmonol; 2009 May; 44(5):436-41. PubMed ID: 19360846
[TBL] [Abstract][Full Text] [Related]
20. Decrease in macrolide resistance and clonal instability among Streptococcus pyogenes in Portugal.
Silva-Costa C; Pinto FR; Ramirez M; Melo-Cristino J;
Clin Microbiol Infect; 2008 Dec; 14(12):1152-9. PubMed ID: 19046174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
